Plus Therapeutics Correlations

PSTV Stock

USD 1.26 0.02 1.56%

The current 90-days correlation between Plus Therapeutics and Aditxt Inc is 0.12 (i.e., Average diversification). The correlation of Plus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Plus Therapeutics Correlation With Market

Significant diversification

The correlation between Plus Therapeutics and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Plus Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Plus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Plus Stock please use our How to Invest in Plus Therapeutics guide.

Moving together with Plus Stock

0.69	HLN	Haleon plc	Pair Corr
0.7	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.65	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.63	RDY	Dr Reddys Laboratories	Pair Corr
0.62	TAK	Takeda Pharmaceutical	Pair Corr
0.62	ZTS	Zoetis Inc	Pair Corr
0.63	LTRN	Lantern Pharma	Pair Corr
0.64	AMGN	Amgen Inc	Pair Corr
0.7	ANEB	Anebulo Pharmaceuticals	Pair Corr

Moving against Plus Stock

0.67	ESPR	Esperion Therapeutics	Pair Corr
0.66	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.61	EBS	Emergent Biosolutions	Pair Corr
0.5	VTRS	Viatris	Pair Corr
0.46	GILD	Gilead Sciences	Pair Corr
0.37	EWTX	Edgewise Therapeutics	Pair Corr
0.36	WAT	Waters	Pair Corr
0.35	BCTXW	BriaCell Therapeutics	Pair Corr
0.34	BFRIW	Biofrontera Warrants	Pair Corr
0.58	BSX	Boston Scientific Corp	Pair Corr
0.48	MNMD	Mind Medicine	Pair Corr
0.46	DXCM	DexCom Inc	Pair Corr
0.42	ABT	Abbott Laboratories Fiscal Year End 22nd of January 2025	Pair Corr
0.36	CPRX	Catalyst Pharmaceuticals	Pair Corr

Related Correlations Analysis

	ADTX	PALI	REVB	QNRX	ZURA	CYTO	IMMX	ENVB	FWBI	DRMA
ADTX		0.55	0.64	-0.01	-0.12	0.91	0.76	0.5	0.82	0.7	ADTX
PALI	0.55		0.28	0.05	0.37	0.72	0.12	0.66	0.73	0.76	PALI
REVB	0.64	0.28		0.19	0.33	0.55	0.62	0.52	0.44	0.45	REVB
QNRX	-0.01	0.05	0.19		0.28	-0.02	0.27	0.46	-0.09	-0.05	QNRX
ZURA	-0.12	0.37	0.33	0.28		0.04	-0.17	0.62	0.17	0.28	ZURA
CYTO	0.91	0.72	0.55	-0.02	0.04		0.57	0.58	0.88	0.69	CYTO
IMMX	0.76	0.12	0.62	0.27	-0.17	0.57		0.3	0.4	0.38	IMMX
ENVB	0.5	0.66	0.52	0.46	0.62	0.58	0.3		0.7	0.61	ENVB
FWBI	0.82	0.73	0.44	-0.09	0.17	0.88	0.4	0.7		0.78	FWBI
DRMA	0.7	0.76	0.45	-0.05	0.28	0.69	0.38	0.61	0.78		DRMA
	ADTX	PALI	REVB	QNRX	ZURA	CYTO	IMMX	ENVB	FWBI	DRMA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CYTO	+ 0.91	ADTX
FWBI	+ 0.88	CYTO
FWBI	+ 0.82	ADTX
DRMA	+ 0.78	FWBI
IMMX	+ 0.76	ADTX
DRMA	+ 0.76	PALI

High negative correlations

IMMX	- 0.17	ZURA
ZURA	- 0.12	ADTX
FWBI	- 0.09	QNRX
DRMA	- 0.05	QNRX
CYTO	- 0.02	QNRX
QNRX	- 0.01	ADTX

Risk-Adjusted Indicators

There is a big difference between Plus Stock performing well and Plus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Plus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ADTX	7.99	(5.95)	0.00	(8.71)	0.00	0.00	6.25	(28.15)	50.07
PALI	3.48	(0.33)	0.00	0.54	0.00	0.00	5.97	(8.55)	24.25
REVB	3.68	(0.72)	0.00	(0.25)	0.00	0.00	8.97	(7.83)	34.52
QNRX	6.04	0.27	0.04	0.29	6.66	(8.76)	17.65	(9.68)	74.46
ZURA	3.79	(0.66)	0.00	(0.19)	0.00	0.00	7.95	(7.94)	26.70
CYTO	3.53	(1.15)	0.00	(8.98)	0.00	0.00	6.98	(10.87)	22.81
IMMX	4.25	(0.12)	(0.02)	0.01	4.55	(5.41)	9.38	(8.22)	32.68
ENVB	3.25	(0.61)	0.00	(3.83)	0.00	0.00	6.25	(7.50)	28.33
FWBI	5.73	(1.60)	0.00	1.01	0.00	0.00	8.65	(14.74)	65.42
DRMA	4.89	(0.60)	0.00	(0.24)	0.00	0.00	9.22	(8.05)	69.06

Plus Therapeutics Corporate Management

John Fraser	Chief Scientist	Profile
Gary CPA	Advisor	Profile
MS MBA	New Strategy	Profile
Marc MD	CEO Pres	Profile
Desiree Smith	Principal Controller	Profile
Andrew Sims	VP CFO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC